why choose us

First received: March 24, 2023

Clinical Trial: Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Lung Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Single-Arm Phase II Study of Personalized Dose Guidance for Stereotactic Body Radiotherapy (SBRT) in Patients With Lung Tumors

Brief Summary: This phase II trial tests the effectiveness and safety of artificial intelligence (AI) to determine dose recommendation during stereotactic body radiation therapy (SBRT) planning in patients with primary lung cancer or tumors that has spread from another primary site to the lung (metastatic).SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision.This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue.Even with the…

Read more